1. Home
2. Products
3. T cell ELISPOT
4. Human
5. IFN-γ
6. Human IFN-γ T cell ELISPOT Ab pair

Human IFN-γ T cell ELISPOT Ab pair

Catalogue Number

CT640-10

Description

Human IFN-γ T cell ELISPOT Ab pair - 10-plate

Format:

10-plate20-plate

Quantity

Add to cart

Price

€ 590.00

Contents

• 2 vials coating antibodies (5-plate format each)
• 2 vials biotinylated detection antibodies (5-plate format each)

Documentation

References list

• Critical parameters in blood processing for T-cell assays: validation on ELISpot and tetramer platforms.
  Afonso, Georgia, et al. J. Immunol. Methods 2010 Jul 31;359: 28-36
• Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients.
  Blancou, Philippe, et al. J. Immunol. 2007 Jun 01;178: 7458-66
• Characterization and biological evaluation of a microparticle adjuvant formulation for plasmid DNA vaccines.
  Evans, Robert K, et al. J Pharm Sci 2004 Jul;93: 1924-39
• Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery.
  Feng, Chengqian, et al. Nat Commun 2021 08 17;12(1): 4984
• Vagaries of the ELISpot assay: specific detection of antigen responsive cells requires purified CD8(+) T cells and MHC class I expressing antigen presenting cell lines.
  Fuchs, Yannick F, et al. Clin. Immunol. 2015 Apr;157: 216-25
• The ADAMTS13 peptide is a dominant HLA-DR1-restricted CD4 T-cell epitope.
  Gilardin, Laurent, et al. Haematologica 2017 Nov;102: 1833-1841
• Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.
  Henriquez, Soledad, et al. Blood 2022 02 10;139: 942-946
• Convalescent plasma therapy for B-cell depleted patients with protracted COVID-19 disease.
  Hueso, Thomas, et al. Blood 2020 Nov 12;136 (20): 2290-2295
• Toxin-neutralizing Abs are associated with improved T cell function following recovery from Staphylococcus aureus infection.
  Kleinhenz, Maureen, et al. JCI Insight 2024 Jan 18;9(4): e173526
• Immune response and severity of Omicron BA.5 reinfection among individuals previously infected with different SARS-CoV-2 variants.
  Li, Lu, et al. Front Cell Infect Microbiol 2023;13: 1277880
• Impaired T lymphocyte responses during childhood Staphylococcus aureus infection.
  Li, Zhaotao, et al. J Infect Dis 2022 Jan 5;225(1): 177-185
• Clinical manifestation and islet β-cell function of a subtype of latent autoimmune diabetes in adults (LADA): positive for T cell responses in phenotypic type 2 diabetes.
  Liang, Huiying, et al. Acta Diabetol 2019 Nov;56(11): 1225-1230
• Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.
  Mallone, R, et al. Diabetes Metab. Res. Rev. 2011 Nov;27: 720-6
• The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
  Martinuzzi, Emanuela, et al. Diabetes 2008 May;57: 1312-20
• Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.
  Santra, Sampa, et al. Nat. Med. 2010 Mar;16: 324-8
• Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation.
  Tan, Chen Sabrina, et al. Biol. Blood Marrow Transplant. 2014 Jul;20: 992-9
• Diagnostic value of combined islet antigen-reactive T cells and autoantibodies assays for type 1 diabetes mellitus.
  Tang, Wei, et al. J Diabetes Investig 2021 Jun;12: 963-969
• Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study.
  Zhao, Bali, et al. Virol Sin 2021 Oct;36(5): 859-868